Dilantin seizure medication

Dilantin is a landmark pharmaceutical product used primarily for the management of generalized tonic-clonic and complex partial seizures. Since its introduction, it has remained a cornerstone in the treatment of epilepsy due to its ability to stabilize neuronal membranes in the brain. The brand is highly recognized globally and is available in various forms, including capsules, chewable tablets, and oral suspensions.

While the brand originated in the United States under the Parke-Davis company, it is now part of the extensive portfolio of Viatris Inc. This change occurred following a series of major pharmaceutical mergers involving Pfizer and Mylan. Manufacturing of Dilantin occurs in multiple specialized facilities across the globe to meet international healthcare demands, with primary production sites often located in North America and Europe.

Today, Dilantin continues to be a trusted name in neurology. Although newer medications have entered the market, its decades of clinical history and established efficacy regarding specific seizure types ensure its continued presence in the medical field under the oversight of Viatris.